» Articles » PMID: 31423619

Sexual Function Recovery After Robot-assisted Radical Prostatectomy: Outcomes from an Italian Referral Centre and Predicting Nomogram

Overview
Journal Andrologia
Date 2019 Aug 20
PMID 31423619
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Aims of this study were to assess sexual recovery after robotic-assisted radical prostatectomy (RARP) and to build a nomogram predicting 1-year sexual function. From May 2015 to July 2016, all patients eligible for RARP at our institution were invited to enter the study. The Expanded Prostate cancer Index Composite (EPIC) questionnaire was administered pre-operatively, then at 45 days, and at 3, 6, 9, and 12 months post-operatively. According to sexual function scores, patients were divided into four classes. Multivariate analysis was used to investigate the influence of patient- and disease-related features on sexual recovery. A total of 643 patients were included. Age was associated with baseline potency (p < .0001). Bioptic Gleason score (GS; p = .0002), American Society of Anesthesiologists (ASA) score ( = .002ASA Physical Status Classification System ) and Charlson Comorbidity Index (CCI; p = .02) were negatively associated with potency. Baseline sexual function was associated with potency recovery. A nomogram resulted from fitting a proportional odds logistic model for ordinal outcomes, with 1-year sexual function as a dependent variable and baseline sexual potency, age, body mass index (BMI), clinical stage, biopsy GS, initial prostate-specific antigen (iPSA), ASA score, and CCI as predictors. After further validation, this nomogram could be a useful tool for the pre-operative counselling.

Citing Articles

Construction for the predictive model of quality of life in patients after robot-assisted radical prostatectomy: a cohort study.

Wu Y, Wang J, Zhou X, Zhu W, Su X, Zeng B Int J Med Sci. 2024; 21(15):2981-2991.

PMID: 39628687 PMC: 11610334. DOI: 10.7150/ijms.100845.


Erectile Dysfunction in Pelvic Cancer Survivors and Current Management Options.

Bernal J, Venkatesan K, Martins F J Clin Med. 2023; 12(7).

PMID: 37048780 PMC: 10095222. DOI: 10.3390/jcm12072697.


Association between overweight, obesity, and quality of life of patients receiving an anticancer treatment for prostate cancer: a systematic literature review.

Depotte L, Caroux M, Gligorov J, Canoui-Poitrine F, Belkacemi Y, De La Taille A Health Qual Life Outcomes. 2023; 21(1):11.

PMID: 36721272 PMC: 9887848. DOI: 10.1186/s12955-023-02093-2.


Development and Validation of Dynamic Multivariate Prediction Models of Sexual Function Recovery in Patients with Prostate Cancer Undergoing Radical Prostatectomy: Results from the MUSIC Statewide Collaborative.

Agochukwu-Mmonu N, Murali A, Wittmann D, Denton B, Dunn R, Montie J Eur Urol Open Sci. 2022; 40:1-8.

PMID: 35638089 PMC: 9142747. DOI: 10.1016/j.euros.2022.03.009.


Applications of artificial intelligence in the diagnosis and prediction of erectile dysfunction: a narrative review.

Xiong Y, Zhang Y, Zhang F, Wu C, Qin F, Yuan J Int J Impot Res. 2022; 35(2):95-102.

PMID: 35027721 DOI: 10.1038/s41443-022-00528-w.